BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 16035649)

  • 1. Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy.
    Matsuura T; Yamagishi S; Kodama Y; Shibata R; Ueda S; Narama I
    Int J Tissue React; 2005; 27(2):59-62. PubMed ID: 16035649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
    Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal capillary changes in Otsuka Long-Evans Tokushima fatty rats (spontaneously diabetic strain). Electron-microscopic study.
    Miyamura N; Bhutto IA; Amemiya T
    Ophthalmic Res; 1999; 31(5):358-66. PubMed ID: 10420121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
    Ishida K; Mizuno A; Sano T; Noma Y; Shima K
    Horm Metab Res; 1995 Sep; 27(9):398-402. PubMed ID: 8557237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
    Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
    Yamabe N; Yokozawa T
    J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus.
    Sakano K; Takahashi M; Mutoh M; Niho N; Komiya M; Sato H; Tanaka T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2007 Oct; 28(10):2193-8. PubMed ID: 17510084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat both before and after the onset of diabetes mellitus.
    Bajotto G; Murakami T; Nagasaki M; Tamura T; Tamura N; Harris RA; Shimomura Y; Sato Y
    Life Sci; 2004 Sep; 75(17):2117-30. PubMed ID: 15312755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defect of an early event of glucose metabolism in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a non-insulin-dependent diabetes mellitus (NIDDM) model.
    Sato T; Magata K; Koga N; Mitsumoto Y
    Biochem Biophys Res Commun; 1998 Apr; 245(2):378-81. PubMed ID: 9571158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical insufficiency in Otsuka Long-Evans Tokushima Fatty rats, a type 2 diabetes mellitus model.
    Noguchi S; Ohno Y; Aoki N
    Metabolism; 2007 Oct; 56(10):1326-33. PubMed ID: 17884440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High salt intake elevated blood pressure but not changed circadian blood pressure rhythm in Otsuka Long-Evans Tokushima Fatty (OLETF) rat.
    Matsumoto M; Tsujino T; Naito Y; Sakoda T; Ohyanagi M; Nonaka H; Masuyama T
    Clin Exp Hypertens; 2009 May; 31(3):271-80. PubMed ID: 19387903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Matsumoto T; Kobayashi T; Kamata K
    Eur J Pharmacol; 2006 May; 538(1-3):132-40. PubMed ID: 16678154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of elevated cardiac expression of TGFbeta1 and endothelin-1 in OLETF diabetic rats by long-acting calcium antagonist.
    Jesmin S; Zaedi S; Maeda S; Mowa CN; Sakuma I; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):907-12. PubMed ID: 16741022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal Neurodegeneration in Type II Diabetic Otsuka Long-Evans Tokushima Fatty Rats.
    Yang JH; Kwak HW; Kim TG; Han J; Moon SW; Yu SY
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3844-51. PubMed ID: 23640038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal changes in Otsuka long-evans Tokushima Fatty rats (spontaneously diabetic rat)--possibility of a new experimental model for diabetic retinopathy.
    Lu ZY; Bhutto IA; Amemiya T
    Jpn J Ophthalmol; 2003; 47(1):28-35. PubMed ID: 12586175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
    Park SY; Choi YH; Lee W
    J Ethnopharmacol; 2008 Feb; 115(3):473-82. PubMed ID: 18068920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids.
    Bajotto G; Murakami T; Nagasaki M; Qin B; Matsuo Y; Maeda K; Ohashi M; Oshida Y; Sato Y; Shimomura Y
    Metabolism; 2006 Mar; 55(3):317-23. PubMed ID: 16483874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Yu Y; Ohmori K; Chen Y; Sato C; Kiyomoto H; Shinomiya K; Takeuchi H; Mizushige K; Kohno M
    J Am Coll Cardiol; 2004 Aug; 44(4):904-13. PubMed ID: 15312879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.